Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $646.73 today based on a ...

The investigation is evaluating Medicare billing protocols, the paper said. UnitedHealth shares sank after the Wall Street Journal reported that the insurer's Medicare billing protocols are under ...

The results beat Wall Street expectations ... Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per share. This story was ...

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from Stephens downgraded the rating on the stock to a ...

The recent price dip presents an exceptional buying opportunity, with Wall Street also bullish, averaging a price target of $500.87, a 30% upside. I am updating my analysis on Elevance Health ...

Elevance Health topped profit and revenue expectations ... Last quarter, Elevance and several competitors fell short of Wall Street's earnings estimates as costs climbed. Elevance's fourth-quarter ...

Here is how Elevance Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Benefit Expense Ratio: 92.4% versus the 15 ...

Elevance Health executives told investors on Thursday morning that they're confident in their 7% to 9% growth targets in Medicare Advantage based on early data coming out of the annual enrollment ...

Shares of major healthcare companies Humana (NYSE: NYSE:HUM), CVS Health (NYSE: NYSE:CVS), Elevance Health, and Cigna (NYSE:CI) fell sharply in Friday's trading session, following a broader industry ...